Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medicare Coverage Of PET Pharmaceutical Agents Needs Revamp, Industry Says

This article was originally published in The Gray Sheet

Executive Summary

A broad range of stakeholders are asking CMS to remove national non-coverage language for newly approved radiopharmaceuticals used in positron emission tomography to allow speedier access to new tools for diagnosing Alzheimer’s and other diseases.

You may also be interested in...

News In Brief

Amgen buys deCode Genetics. CMS opens proposed decision memo on PET radiopharmaceuticals. More news briefs.

Reimbursement In Brief

CMS opens national coverage analysis for PET tracers to diagnose dementia. HHS Office of Inspector General reports on prosthetics and orthotics payments. More reimbursement news.

News In Brief

Judge rejects Orthofix settlement with feds. ConvaTec purchases catheter-provider 180 Medical. Cook announces new product division. More news briefs.

Related Content


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts